Neurodiagnostics Market Size To Hit New profit-making Growth By 2030

Latest Research Study on “neurodiagnostics Market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Region Outlook, And Segment Forecasts, 2021 – 2030”.

The Global neurodiagnostics market size is expected to Rake US$ 28.3 billion by 2030 and is anticipated to grow at a CAGR of 13.5% during forecast period 2021 to 2030.

Get Sample Copy of This [email protected] https://www.visionresearchreports.com/report/sample/38041

Report Highlights

  • Increased life expectancy has resulted in an increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer’s disease and Parkinson’s disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.

  • CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.

  • Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently, no commercial biomarker is available in the market, extensive clinical research is happening to find out the perfect combinations of the biomarkers.

  • North America held the major market share of around 36% in the year 2020 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit the highest CAGR of 4% over the forecast period. 

Key Players

GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), and Nihon Kohden Corporation (Japan) among others.

Market Segmentation

Technology Outlook

  • Neuroimaging Technologies

    • Computed Tomography (CT)

    • Magnetic Resonance Imaging (MRI)

    • Nuclear Medicine Imaging (PET, SPECT)

    • Near Infrared Spectroscopic Imaging (NIRS)

    • Electroencephalography (EEG)

    • Magnetoencephalography (MEG)

    • Voxel-based Morphometry (VBM)

  • In Vitro Diagnostics

  • Neuroinformatics

Regional Outlook 

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • The Middle East and Africa

    • South Africa

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Leave a Reply

Your email address will not be published.